ATNM Actinium Pharmaceuticals, Inc.
NYSE · SEC CIK 1388320 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 35 since 2021-09-03, latest 2026-09-04 17:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Chell Jeffrey W. | Dir | — | — |
| Shetty Ajit | Dir | — | — |
| Nicholson, C. David | Dir | — | — |
| SETH SANDESH | CEO, Dir | — | — |
| Almenoff June Sherie | Dir | — | — |
| Steinhart Richard I | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-04 17:00 | 2026-09-02 | ATNM | Shetty Ajit | Dir | A - Grant | $0.00 | +61.6K | 62.4K | +8,137% | $0 |
| D | 2026-09-04 17:00 | 2026-09-02 | ATNM | Nicholson, C. David | Dir | A - Grant | $0.00 | +62.8K | 63.3K | +12,560% | $0 |
| DT | 2026-09-04 17:00 | 2026-09-02 | ATNM | Almenoff June Sherie | Dir | A - Grant | $0.00 | +18.0K | 18.0K | New | $0 |
| DM | 2026-09-04 17:00 | 2026-09-02 | ATNM | SETH SANDESH | CEO, Dir | A - Grant | $0.00 | +1.78M | 1.97M | +965% | $0 |
| D | 2026-09-04 17:00 | 2026-09-02 | ATNM | Steinhart Richard I | Dir | A - Grant | $0.00 | +62.8K | 63.1K | +19,873% | $0 |
| D | 2026-09-04 17:00 | 2026-09-02 | ATNM | Chell Jeffrey W. | Dir | A - Grant | $0.00 | +61.6K | 61.6K | New | $0 |
| 2025-08-20 | 2025-08-18 | ATNM | SETH SANDESH | CEO, Dir | F - Tax | $1.71 | -120.9K | 184.5K | -40% | -$206.7K | |
| 2022-08-19 | 2022-08-17 | ATNM | SETH SANDESH | CEO, Dir | A - Grant | $0.00 | +300.0K | 305.4K | +5,575% | $0 |
Purchase Sale Sale after option exercise All abbreviations